4//SEC Filing
VERTEX PHARMACEUTICALS INC / MA 4
Accession 0001209191-14-065906
$VRTXCIK 0000875320operating
Filed
Nov 2, 7:00 PM ET
Accepted
Nov 3, 5:41 PM ET
Size
5.8 KB
Accession
0001209191-14-065906
Insider Transaction Report
Form 4
Connolly Thomas
SVP, Human Resources
Transactions
- Award
Common Stock
2014-10-30$0.01/sh+20,000$200→ 34,895 total
Holdings
- 150(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]Performance-based retention award that will vest if performance objectives are achieved prior to November 15, 2019. The award will vest on October 30, 2017 (or, if later, the day following the earnings release for the third quarter of 2017) if the Company achieves positive EBITDA for the 12-month period ending September 30, 2017. Between January 1, 2018 and November 15, 2019, if the Company achieves positive EBITDA for a 12-month period ending on a calendar quarter, the award will vest on the day following the applicable earnings release.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeoperating
IncorporatedMA
Related Parties
1- filerCIK 0000875320
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 7:00 PM ET
- Accepted
- Nov 3, 5:41 PM ET
- Size
- 5.8 KB